These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18381411)

  • 1. Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients.
    Dairkee SH; Seok J; Champion S; Sayeed A; Mindrinos M; Xiao W; Davis RW; Goodson WH
    Cancer Res; 2008 Apr; 68(7):2076-80. PubMed ID: 18381411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propagation of genetically altered tumor cells derived from fine-needle aspirates of primary breast carcinoma.
    Li Z; Bustos V; Miner J; Paulo E; Meng ZH; Zlotnikov G; Ljung BM; Dairkee SH
    Cancer Res; 1998 Dec; 58(23):5271-4. PubMed ID: 9850046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bisphenol A on breast cancer and its risk factors.
    Yang M; Ryu JH; Jeon R; Kang D; Yoo KY
    Arch Toxicol; 2009 Mar; 83(3):281-5. PubMed ID: 18843480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Claudin-16 reduces the aggressive behavior of human breast cancer cells.
    Martin TA; Harrison GM; Watkins G; Jiang WG
    J Cell Biochem; 2008 Sep; 105(1):41-52. PubMed ID: 18442037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months.
    Frank DH; Kimler BF; Fabian CJ; Ranger-Moore J; Yozwiak M; Bartels HG; Alberts DS; Bartels PH
    Breast Cancer Res Treat; 2009 Jun; 115(3):661-8. PubMed ID: 19125322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
    Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H
    Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer.
    Aruga T; Suzuki E; Saji S; Horiguchi S; Horiguchi K; Sekine S; Kitagawa D; Funata N; Toi M; Sugihara K; Kuroi K
    Oncol Rep; 2009 Aug; 22(2):273-8. PubMed ID: 19578766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation in benign breast epithelium in relation to age and breast cancer risk.
    Euhus DM; Bu D; Milchgrub S; Xie XJ; Bian A; Leitch AM; Lewis CM
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1051-9. PubMed ID: 18483325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-expression of metallothionein predicts chemoresistance in breast cancer.
    Yap X; Tan HY; Huang J; Lai Y; Yip GW; Tan PH; Bay BH
    J Pathol; 2009 Mar; 217(4):563-70. PubMed ID: 19116991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific increase of human kallikrein 4 mRNA and protein levels in breast cancer stromal cells.
    Mangé A; Desmetz C; Berthes ML; Maudelonde T; Solassol J
    Biochem Biophys Res Commun; 2008 Oct; 375(1):107-12. PubMed ID: 18687310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.
    Huang X; Gao L; Wang S; Lee CK; Ordentlich P; Liu B
    Cancer Res; 2009 Nov; 69(21):8403-11. PubMed ID: 19826038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer.
    Van Laere S; Beissbarth T; Van der Auwera I; Van den Eynden G; Trinh XB; Elst H; Van Hummelen P; van Dam P; Van Marck E; Vermeulen P; Dirix L
    Clin Cancer Res; 2008 Nov; 14(22):7452-60. PubMed ID: 19010862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
    Voduc D; Nielsen TO; Cheang MC; Foulkes WD
    Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
    Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
    Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of CD55 expression in breast cancer.
    Ikeda J; Morii E; Liu Y; Qiu Y; Nakamichi N; Jokoji R; Miyoshi Y; Noguchi S; Aozasa K
    Clin Cancer Res; 2008 Aug; 14(15):4780-6. PubMed ID: 18676748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52.
    Shehata M; Bièche I; Boutros R; Weidenhofer J; Fanayan S; Spalding L; Zeps N; Byth K; Bright RK; Lidereau R; Byrne JA
    Clin Cancer Res; 2008 Aug; 14(16):5050-60. PubMed ID: 18698023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.
    Rhee J; Han SW; Oh DY; Kim JH; Im SA; Han W; Park IA; Noh DY; Bang YJ; Kim TY
    BMC Cancer; 2008 Oct; 8():307. PubMed ID: 18947390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.